$10.08
-0.60 (-5.62%)
Open$10.84
Previous Close$10.68
Day High$11.19
Day Low$10.01
52W High$27.50
52W Low$10.01
Volume—
Avg Volume2.81M
Market Cap2.32B
P/E Ratio—
EPS$-0.61
SectorN/A
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 377.06M | 353.35M | 309.67M |
| Net Income | 46.76M | 35.75M | 36.05M |
| Profit Margin | 12.4% | 10.1% | 11.6% |
| EBITDA | 57.07M | 51.63M | 50.21M |
| Free Cash Flow | 46.45M | 42.52M | 46.04M |
| Rev Growth | -2.7% | +10.3% | -0.7% |
| Debt/Equity | 0.35 | 0.35 | 0.32 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.81 | +4.46% | — | 1.75B |
| PICS | Pics Nv | $12.80 | -3.03% | 6.8 | 1.56B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.20% | 75.0 | 644.01M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 593.79M |
| BCSS | Bain Capital Gss Inv- A | $10.22 | +0.00% | 71.9 | 596.26M |